James Mulé

James Mulé

Director/Board Member at CG ONCOLOGY, INC.

Net worth: - $ as of 2024-04-29

72 year
Consumer Services
Finance
Technology Services

Profile

James J.
Mulé
is an Independent Director at CG Oncology, Inc., a Director at Moffitt Technologies Corp., and an Advisor at ORI Capital Investment Advisory Hong Kong Ltd.
He was formerly a Director at Empower AI, Inc., Director-Tumor Immunology & Immunotherapy at the University of Michigan, Director at the National Cancer Institute, EVP & Associate Center Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc., and an Independent Director at Fulgent Genetics, Inc. He is also an Adjunct Faculty member at Stanford University and an Advisor at Select BioVentures LLC.
Mulé received his undergraduate degree from New Jersey City University, his graduate degree from UW Medicine, and his doctorate from UW Graduate School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-24 0 ( -.--% ) - $ 2024-04-29

James Mulé active positions

CompaniesPositionStart
CG ONCOLOGY, INC. Director/Board Member 2018-10-21
Moffitt Technologies Corp. Director/Board Member 2008-12-31
Translational Research In Oncology Corporate Officer/Principal -
Consultant / Advisor -
All active positions of James Mulé

Former positions of James Mulé

CompaniesPositionEnd
FULGENT GENETICS, INC. Director/Board Member 2020-05-26
Director/Board Member -
NCI INC Corporate Officer/Principal -
Consultant / Advisor -
University of Michigan Corporate Officer/Principal -
See the detail of James Mulé's experience

Training of James Mulé

New Jersey City University Undergraduate Degree
UW Medicine Graduate Degree
UW Graduate School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Mulé's experience

Connections

31

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
CG ONCOLOGY, INC.

Health Technology

FULGENT GENETICS, INC.

Health Services

Private companies7

Technology Services

Miscellaneous

Commercial Services

Finance

Moffitt Technologies Corp.

Finance

Translational Research In Oncology

See company connections